Medical Packaging Market Driven By Amcor, SGD Pharma; 3M; West Pharmaceutical Services, Sonoco Products Company, CCL Industries

According to our latest research study on “Medical Packaging Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type, Material, and Application,” the market is projected to reach US$ 169,183.91 million by 2028 from US$ 109,238.35 million in 2021; it is expected to grow at a CAGR of 6.4% from 2021 to 2028. The report highlights trends prevailing in the market and the factors driving and restraining the market growth.

Based on type, the global medical packaging market is segmented into containers, pouches, trays, blister packets, vials, and others. In 2021, the containers segment held the largest share of the market, by type. However, the blister packets segment is estimated to grow at a significant CAGR during the forecast period due to increasing product developments and product launches.

Download sample PDF Copy at: https://www.theinsightpartners.com/sample/TIPRE00005546/?utm_source=OpenPR&utm_medium=10144

The growth of the market is attributed to key driving factors such as increased emphasis on convenience and environmental issues and rise in demand for counterfeit prevention mechanisms. However, fluctuations in prices of raw materials are expected to restrict the market growth to a certain extent during the forecast period.

Amcor plc; DuPont de Nemours, Inc.; Mitsubishi Chemical Corporation; SGD Pharma; 3M; West Pharmaceutical Services, Inc; Avery Dennison Corporation; Sonoco Products Company; CCL Industries Inc.; and WestRock Company are among the major companies operating in the market.

Medical packaging requires a high quality of sterility to ensure that the product is free from contamination. These medical packaging systems increase patient safety and enhance packaging performance. Factors such as increased emphasis on convenience and environmental issues and rise in demand for counterfeit prevention mechanisms are driving the medical packaging market. However, fluctuations in prices of raw materials are expected to restrict the market growth to a certain extent during the forecast period.

The threat that counterfeit medicines pose to the global pharmaceutical sector is immense. From fake formulations to issues in the manufacturing process, some industry figures believe we could be looking at revenue losses up to EUR 27 billion in Europe alone. The International Hologram Manufacturers Association (IHMA) is a good source of expertise in this field and highlights an industry report that indicates continued growth for anti-counterfeiting packaging technologies. According to the IHMA, the “Anti-counterfeiting, Authentication and Verification Technologies” report signals the added expertise holography brings to the authentication of packaging products. Technological innovation within the anti-counterfeiting, authentication, and verification technologies is a significant factor contributing to the market's growth.

By Geography

North America
US
Canada
Mexico
Europe
France
Germany
UK
Spain
Italy
Rest of Europe
Asia Pacific (APAC)
China
India
Japan
Australia
South Korea
Rest of Asia Pacific
Middle East & Africa (MEA)
Saudi Arabia
UAE
South Africa
Rest of Middle East & Africa
South and Central America (SCAM)
Brazil
Argentina
Rest of South and Central America

Place an Order Copy at: https://www.theinsightpartners.com/buy/TIPRE00005546/?utm_source=OpenPR&utm_medium=10144

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Semiconductors, Healthcare, Manufacturing, Automotive and Defense.

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

This release was published on openPR.